close

Leadership

Our senior leaders include the Brisbane Diamantina Health Partners Board, the Brisbane Diamantina Health Partners Executive and Theme Leaders.

BDHP Board

The Brisbane Diamantina Health Partners Board sets the strategic direction for Brisbane Diamantina Health Partners. We have representatives from each of our partners.

Robin Mortimer

Dr Robin Mortimer AO

FRACP FACP

Chairman, Brisbane Diamantina Health Partners

view bio

Dr Mortimer is an internationally recognised physician and until recently held the position of President of the Australian Medical Council.

He has previously held the following positions:

  • Senior Staff Specialist and Director, Department of Endocrinology, Royal Brisbane & Women’s Hospital
  • Director, Conjoint Endocrine Laboratory, Queensland Health Pathology Services & Royal Brisbane & Women’s Hospital,
  • Professor, School of Medicine, The University of Queensland
  • Adjunct Professor, School of Biomedical Sciences, Queensland University of Technology
  • Executive Director, Office of Health and Medical Research, Queensland Health
Stephen Ayre Image

Dr Stephen Ayre

MBBS MPH FRACMA

Executive Director, PAH-QEII Health Network , Metro South Health
Brisbane Diamantina Health Partners

view bio

Dr Stephen Ayre was appointed to the position of Executive Director Princess Alexandra Hospital (PAH) and QEII Jubilee Hospital (QEII) Health Network, Metro South Hospital and Health Service, Brisbane on 5 May 2014. Stephen was previously the Executive Director Medical Services – The Prince Charles Hospital (TPCH).

Dr Ayre is a graduate of the University of Queensland (UQ) Medical School, has a Masters in Health Administration from the University of NSW and is a Fellow of the Royal Australasian College of Medical Administrators (RACMA). He currently is the Jurisdictional Coordinator of Training for the College of Medical Administrators.

In the past he has worked as a general practitioner on the Sunshine Coast after postgraduate experience in a number of Queensland Hospitals. During his work in general practice he developed an interest in Alcohol and Drug Medicine and Community Medicine and is a member of the Australasian Professional Society for Alcohol and Drugs.

Dr Ayre’s appointments with Queensland Health have included Director of Community Health – Sunshine Coast, Medical Superintendent – Caboolture Hospital, Deputy Executive Director Medical Services – Royal Brisbane Hospital and Medical Superintendent for the Royal Women’s Hospital (RWH). In Tasmania, he was the CEO of the Launceston General Hospital (2004-2008) and acted as the CEO for all three northern Tasmanian Hospitals for a prolonged period.

His interests are in the areas of safety and quality in complex health environments, accelerated process redesign and the hospital community interface.

scott-bell

Professor Scott Bell

MBBS MD FRACP

Executive Director – Research
Metro North Hospital and Health Service

view bio

Professor Scott Bell is Executive Director – Research, MNHHS and a Senior Physician of the Adult Cystic Fibrosis Centre at TPCH (>300 patients) where he has worked since 1996. He is currently the Editor-in-Chief of the Journal of Cystic Fibrosis. He leads the Lung Bacteria Laboratory at QIMR Berghofer Medical Research Institute in Brisbane. Scott has over 180 peer reviewed publications and has received grant support in excess of $10 million over the past 10 years.

His research interests include the CF microbiology, acquisition pathways for human infection and has a long history of supporting multi-disciplinary research.

Robyn-Ward

Professor Robyn Ward

Deputy Vice-Chancellor (Research)
Faculty of Medicine and Biomedical Science
The University of Queensland

view bio

Prof Robyn Ward is Deputy Vice-Chancellor (Research) and Acting Executive Dean Faculty of Medicine and Biological Sciences at the University of Queensland. She is also a Visiting Medical Officer (Oncology) at Princess Alexandria Hospital, Brisbane. She came to these roles from a professional background as a staff specialist in medical oncology, and with over 20 years experience in lab-based, clinical and health services research.

As an oncologist, her particular clinical interests have been in the medical management of colorectal cancer, hereditary cancer, and the rational use of cancer therapeutics. Prof Ward was UNSW Chair of Medicine at Prince of Wales Hospital until 2014, and Director of the Cancer Centre at Prince of Wales Hospital until 2016. She drove the establishment and construction of The Bright Alliance – which included the Nelune Comprehensive Cancer Centre, the $24 million Scientia Clinical Research facility (SCR) for early clinical trials and a Childrens health research centre. For the Commonwealth, she is a long standing member of the Pharmaceutical Benefits Advisory Committee and since 2009 has Chaired the Medical Services Advisory Committee.

In 2013 she was elected to the Council and Executive of the Australian Academy of Health and Medical Sciences, and was made Member of the Order of Australia (AM) for significant service to patient care in the field of oncology.

frank-gannon

Professor Frank Gannon

MRIA FAHMS

Director and Chief Executive Officer
QIMR Berghofer Medical Research Institute

view bio

Professor Frank Gannon is the Director and CEO of the QIMR Berghofer Medical Research Institute. He joined QIMR Berghofer in January 2011, having been Director General and board member of Science Foundation Ireland (SFI) since 2007. He obtained his PhD from the University of Leicester, England in 1973 and worked subsequently in the USA, France, Ireland and Germany where he was Executive Director of the European Molecular Biology Organisation (EMBO) from 1994–2007.

shane-kelly-2

Dr Shane Kelly

MBBS MBA MPH FRACMA FAICD

Group CEO
Mater Misericordiae Ltd

view bio

Dr Kelly commenced in the role of Chief Executive Officer, Mater Health Services in July 2015. Prior to this appointment, Dr Kelly was Chief Executive of the North Metropolitan Health Service in Western Australia.

Dr Kelly completed his medical degree at the University of Western Australia, following which he worked at Sir Charles Gairdner Hospital, a large adult tertiary teaching hospital in Perth. He went on to complete a Masters of Business Administration and Masters of Public Health and took on health service-based senior management roles including as the Chief Executive of the Womens and Childrens Health Service and subsequently the South Metropolitan Health Service in Western Australia.

Prior to joining the North Metropolitan Health Service, Dr Kelly spent eight years as the Chief Executive Officer of St John of God Subiaco Hospital, the flagship and largest hospital of the St John of God Health Care group, a Catholic not-for-profit Australian private health care organisation.

Dr Kelly is a Fellow of both the Royal Australasian College of Medical Administrators and the Australian Institute of Company Directors. His main professional interests are in relation to health system performance and accountability, and the provision of safe, high quality evidence based patient care.

fionnagh-dougan-2

Ms Fionnagh Dougan

BA (Hons)Dip (Health)RN RMN FAICD

Chief Executive
Childrens Health Queensland

view bio

Fionnagh has a long and successful history in leading change in complex healthcare environments and a lifelong commitment to improving childrens health. She was appointed Chief Executive of Childrens Health Queensland in January 2015. Prior to this, she had overarching responsibility for all hospital, clinical support and community services, including paediatric and mental health services, in her role as Director of Provider Services, Auckland District Health Board (ADHB). She is also a former General Manager of Aucklands Starship Childrens Hospital and Child Health Services. Fionnagh began her career in nursing at the Royal Infirmary of Edinburgh and has postgraduate qualifications in health management, an honours degree in communication and media, and has held dual registration and experience as both a mental health and a general nurse.

Carolyn-Mountford

Professor Carolyn Mountford

M.Sc. Biophysics, D.Phil. Biochemistry & Biophysics, M.S. Radiology

CEO and Director of Research
Translational Research Institute

view bio

Professor Mountford is co-inventor of the diagnostic protocol to monitor women at high risk for breast cancer identifying metabolic deregulations in their breast tissue that precede tumour growth. The same technology is shown to identify changes to the brain associated with learning, memory, PTSD and injury from blast and impact. Her team is under contract to the USA and Australian military to develop this approach to improve the health of soldiers.

Prior to her appointment at TRI, Professor Mountford was Professor of Radiology at Harvard Medical School and Director of the Centre for Clinical Spectroscopy at the Brigham and Women’s Hospital.  She was also Professor of Radiology and Director of the Centre for MR in Health at the University of Newcastle.

Her team has been a worldwide development site for Siemens since 1999. She has led multidisciplinary programs interfacing these teams with industry; translating the technology; and making it available worldwide.

ross_young

Professor Ross Young

Executive Dean
Faculty of Health, Queensland University of Technology

view bio

Professor Ross Young was appointed Executive Dean, Faculty of Health QUT in January 2013 following seven years as Executive Director, Institute of Health and Biomedical Innovation (IHBI), QUT. Professor Young is a Clinical Psychologist and his research interests lie in the integration of psychological and biological risk factors in mental illness. His research includes work in substance misuse, schizophrenia, anxiety disorders, mood disorders and more broadly in behavioural medicine. This includes work in pharmacogenomics and the development of personalised medicine via the use of gene chips. Professor Young has over 230 published book chapters and papers in genetic, medical, psychiatric and psychological journals.
His roles have included:

  • Executive Dean, Faculty of Health, QUT
  • Executive Director – Institute of Health and Biomedical Innovation, QUT
  • Visiting Research Fellow – Alcohol Research Centre, UCLA
  • Honorary Professor, School of Medicine, The University of Queensland
  • Honorary Professor, Department of Psychology, Glasgow University, Scotland
  • Senior Clinical Psychologist, Princess Alexandra Hospital, Brisbane
  • Registered Clinical Psychologist
  • Chairman of the Board, Mantle Pty- an organisation developing community based housing for those with mental illness.
  • Patron, Mental Health Carers, Arafmi Queensland
  • Past Chair, Queensland Institutes of Health
  • Past National President, Australian Society for Cognitive and Behaviour Therapy
  • Fellow of the Queensland Academy of Arts and Sciences
  • AACBT Honorary Fellow
michaelwalsh

Mr Michael Walsh

MBA, BA (Hons), BEd, BSc

Director-General
Department of Health, Queensland Government

view bio

Mr Walsh is the Director-General Queensland Health where he leads a public health and hospital system for a population of 4.7million people.  Prior to this role, Mr Walsh was the inaugural Chief Executive / CIO of eHealth NSW, providing eHealth and ICT services to the NSW Health System.  Michael has also worked as Chief Executive of HealthShare NSW, the NSW Health shared service provider. Michael has extensive experience at the Government Senior Executive level in both NSW and Queensland and has worked in the private sector including for a leading consulting firm.

Mr Walsh has led large organisational strategy and change programs including major departmental integrations; significant ICT programs; and, large hospital infrastructure programs such as the $10 billion Queensland Hospital rebuilding program including the Gold Coast University Hospital, Sunshine Coast University Hospital and Queensland Children’s Hospital.

Mr Walsh has a strong background in public sector governance and leadership. He also has strong experience in portfolio, program and project management, business case development and implementation of major government initiatives.

Sue-Scheinpflug-Resized

Sue Scheinpflug

BEd

CEO
Brisbane South PHN

view bio

Sue has been a CEO for over 19 years.  She has worked in the areas of primary health care, mental health, homelessness, youth and families and education.  Sue is the CEO of Brisbane South PHN and a board member of the West Moreton Hospital and Health Service.

Sue has held numerous advisory and policy development roles and government appointments in the community services and regional development sectors.

Sue holds degrees in teaching and education and is a graduate of the Australian Institute of Company Directors.  She has won multiple awards as a business and community leader including the 2009 Queensland Telstra Business Woman of the Year Award.

Executive

Areti Gavrilidis

Areti Gavrilidis

Areti Gavrilidis is the General Manager of Brisbane Diamantina Health Partners. She has a business, health and science background, working in both the public and private sectors.

view bio

In 2002 she moved from Austin Health to the Princess Alexandra Hospital Centres for Health Research to support, facilitate and strengthen health and medical research within the hospital campus. In 2007 she was appointed as the Principal Researcher, working with the Smart State Council to prepare a report to advance Queensland’s health and medical research and development outcomes, which led directly to the establishment of Queensland Health’s Office of Health and Medical Research.

In 2008 Ms Gavrilidis was awarded a Churchill Trust Fellowship to study models facilitating translational research. After visiting over 40 prestigious leading research Academic Health Science organisations in the USA, Canada and the UK and interviewing over 130 key individuals, she has applied this international knowledge to her current position.

In 2008 she was a recipient of an Australasian Research Management Society (ARMS)– International Network of Research Management Societies Scholarship.

She has qualifications in science and applied science, and this scientific background is strengthened by her interest and experience in business management and augmented with a postgraduate degree in Business and a Masters in Business Administration. Over the years she has served on a number of local, national and international committees and boards including the ARMS International Committee.

Theme Leaders

Our Theme Leaders play a critical role in developing, co-ordinating and leading our nine Themes.

prof-len-gray

Professor Len Gray

Ageing Theme

nancy-pachana-image

Professor Nancy Pachana

Ageing Theme

john-mcgrath

Professor John McGrath

Brain and Mental Health Theme

QIMR phototonyphillips.com

Professor Geoff Hill

Cancer Theme

prof-walpole-image

Professor Euan Walpole

Cancer Theme

prof-soyer-image

Professor H. Peter Soyer

Skin and Skin Cancer

mark-smithers-image

Professor B. Mark Smithers

Skin and Skin Cancer Theme

prof-ian-frazer-image

Professor Ian Hector Frazer

Skin and Skin Cancer Theme

ian-yang-image

Professor Ian Yang

Chronic Disease Theme

Dr Ian Scott - Image

Associate Professor Ian Scott

Evidence and Innovation in Clinical Care Theme

dr-nick-graves-image

Professor Nicholas Graves

Evidence and Innovation into Clinical Care Theme

OLYMPUS DIGITAL CAMERA

Professor Geoffrey Playford

Immunity, Inflammation, Infection Theme

prof-geoff-cleghorn

Professor Geoff Cleghorn

Maternal and Child Health Theme

moritz-lab-picture5191-023

Professor Karen Moritz

Maternal and Child Health Theme

prof-jeff-lipman-image

Professor Jeffery Lipman

Trauma, Critical Care and Recovery Theme